World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
55
Citations
12861
World Ranking
3788
National Ranking
1736

Elizabeth Connick publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Elizabeth Connick sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 151 publications — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Elizabeth Connick D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Elizabeth Connick sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 55 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Elizabeth Connick is affiliated with the University of Arizona in the United States and has contributed extensively to the fields of Medicine and Immunology and Microbiology. Their research primarily focuses on Infectious Diseases, Immunology, Virology, Epidemiology, and Oncology.

The main topics of their work include:

  • HIV Research and Treatment
  • HIV/AIDS Research and Interventions
  • Immune Cell Function and Interaction
  • HIV/AIDS Drug Development and Treatment
  • HIV-Related Health Complications and Treatments
  • T-cell and B-cell Immunology
  • HIV, Drug Use, Sexual Risk

Recent papers by Elizabeth Connick reflect their engagement in HIV and immunotherapy research. Notable publications include:

  • "HIV post-treatment controllers have distinct immunological and virological features" (2023) in Proceedings of the National Academy of Sciences
  • "CAR/CXCR5-T cell immunotherapy is safe and potentially efficacious in promoting sustained remission of SIV infection" (2022) in PLoS Pathogens
  • "HIV-1-Specific Chimeric Antigen Receptor T Cells Fail To Recognize and Eliminate the Follicular Dendritic Cell HIV Reservoir In Vitro" (2020) in Journal of Virology
  • "A constitutive interferon-high immunophenotype defines response to immunotherapy in colorectal cancer" (2025) in Cancer Cell
  • "Autologous neutralizing antibodies increase with early antiretroviral therapy and shape HIV rebound after treatment interruption" (2023) in Science Translational Medicine

Elizabeth Connick frequently collaborates with several researchers active in similar areas. Frequent co-authors include Paul A. Volberding, Daniel J. Skiest, Jonathan Z. Li, Behzad Etemad, and Yijia Li.

Their work has appeared repeatedly in specific academic venues, emphasizing fields relevant to their research interests. Common publication venues include UNC Libraries, bioRxiv (Cold Spring Harbor Laboratory), PLoS Pathogens, Journal of Virology, and Frontiers in Immunology.

Best Publications

  • Antiretroviral-Drug Resistance among Patients Recently Infected with HIV

    Susan J. Little;Sarah Holte;Jean Pierre Routy;Eric S. Daar

  • Immunologic Responses Associated with 12 Weeks of Combination Antiretroviral Therapy Consisting of Zidovudine, Lamivudine, and Ritonavir: Results of AIDS Clinical Trials Group Protocol 315

    Michael Marcel Lederman;Elizabeth Connick;Alan Landay;Daniel R. Kuritzkes

  • Prolonged survival and tissue trafficking following adoptive transfer of CD4ζ gene-modified autologous CD4+ and CD8+ T cells in human immunodeficiency virus–infected subjects

    Ronald T. Mitsuyasu;Peter A. Anton;Steven G. Deeks;David T. Scadden

  • A potential role for interleukin-7 in T-cell homeostasis

    Terry J. Fry;Elizabeth Connick;Judith Falloon;Michael Marcel Lederman

  • Reduced Antiretroviral Drug Susceptibility Among Patients With Primary HIV Infection

    Susan J. Little;Eric S. Daar;Richard T. D'Aquila;Philip H. Keiser

  • Inadequate T follicular cell help impairs B cell immunity during HIV infection

    Rafael A. Cubas;Joseph C. Mudd;Anne Laure Savoye;Matthieu Perreau

  • Impact of circadian misalignment on energy metabolism during simulated nightshift work

    Andrew W. McHill;Edward L. Melanson;Janine Higgins;Elizabeth Connick

  • Programmed Death 1 Expression on HIV-Specific CD4+ T Cells Is Driven by Viral Replication and Associated with T Cell Dysfunction

    Michelle D’Souza;Andrew P. Fontenot;Doug G. Mack;Catherine Lozupone

  • Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced disease.

    Hernan Valdez;Elizabeth Connick;Elizabeth Connick;Kimberly Y. Smith;Kimberly Y. Smith;Michael M. Lederman

  • CTL Fail to Accumulate at Sites of HIV-1 Replication in Lymphoid Tissue

    Elizabeth Connick;Teresa Mattila;Joy M. Folkvord;Rick Schlichtemeier

  • Immune Reconstitution in the First Year of Potent Antiretroviral Therapy and Its Relationship to Virologic Response

    Elizabeth Connick;Michael Marcel Lederman;Brian L. Kotzin;John Spritzler

  • Thymic Size and Lymphocyte Restoration in Patients with Human Immunodeficiency Virus Infection after 48 Weeks of Zidovudine, Lamivudine, and Ritonavir Therapy

    Kimberly Y. Smith;H. Valdez;A. Landay;J. Spritzler

  • Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen

    Hernan Valdez;Kimberly Y. Smith;Alan Landay;Elizabeth Connick

  • HIV-1 infection and CD4 T cell depletion in the humanized Rag2 -/- γc -/- (RAG-hu) mouse model

    Bradford K Berges;William H Wheat;Brent E Palmer;Elizabeth Connick

  • Sex, Race, and Geographic Region Influence Clinical Outcomes Following Primary HIV-1 Infection

    Amie L. Meditz;Samantha MaWhinney;Amanda Allshouse;William Feser

  • Rapid Accumulation of Human Immunodeficiency Virus (HIV) in Lymphatic Tissue Reservoirs during Acute and Early HIV Infection: Implications for Timing of Antiretroviral Therapy

    Timothy Schacker;Susan Little;Elizabeth Connick;Kristin Gebhard-Mitchell

  • The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies

    Golnaz Namazi;Jesse M Fajnzylber;Evgenia Aga;Ronald J Bosch

  • Mucosal transmission of R5 and X4 tropic HIV-1 via vaginal and rectal routes in humanized Rag2−/−γc−/− (RAG-hu) mice

    Bradford K. Berges;Sarah R. Akkina;Joy M. Folkvord;Elizabeth Connick

  • In vivo analysis of Fas/FasL interactions in HIV-infected patients.

    Andrew D. Badley;David H. Dockrell;Alicia Algeciras;Steve Ziesmer

  • Lymphoid follicles are sites of heightened human immunodeficiency virus type 1 (HIV-1) replication and reduced antiretroviral effector mechanisms.

    Joy M. Folkvord;Carl Armon;Elizabeth Connick

  • Prolonged survival and tissue trafficking following adoptive transfer of CD 4 z gene-modified autologous CD 4 1 and CD 8 1 T cells in human immunodeficiency virus – infected subjects

    Unknown

Frequent Co-Authors

Daniel R. Kuritzkes
Daniel R. Kuritzkes Brigham and Women's Hospital
Alan L. Landay
Alan L. Landay The University of Texas Medical Branch at Galveston
Michael M. Lederman
Michael M. Lederman Case Western Reserve University
Susan J. Little
Susan J. Little University of California, San Diego
Harold A. Kessler
Harold A. Kessler Rush University Medical Center
Douglas D. Richman
Douglas D. Richman University of California, San Diego
Martin D. McCarter
Martin D. McCarter University of Colorado Anschutz Medical Campus
Ronald J. Bosch
Ronald J. Bosch Harvard University
Bruce D. Walker
Bruce D. Walker Harvard University
Eric S. Daar
Eric S. Daar Lundquist Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related online degrees can broaden your career options in healthcare and research. For example, many students begin with practical nursing roles by enrolling in easy LPN programs to get into. These programs offer a quicker entry into nursing, providing foundational skills that complement immunology expertise.

Advancing further, becoming a nurse practitioner often aligns well with immunology backgrounds, especially through accessible routes like the easiest FNP program. These programs tend to have flexible admission requirements, making it feasible to transition into specialized practice.

For those interested in mental health alongside immunological studies, exploring top programs is critical. The top PMHNP programs provide strong clinical placements, ensuring that students gain hands-on experience in psychiatric mental health nursing.

Cost is often a concern for prospective students. Luckily, there are options like affordable PMHNP programs that balance quality education with manageable tuition, making advanced degrees more accessible to a diverse learner population.

Best Scientists Citing Elizabeth Connick

Trending Scientists

Recently Published Articles